Stock Financial Ratios


DEPO / DepoMed, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price7.77
Volume820,300.00
Market Cap ($M)513.43
Enterprise Value ($M)241.68
Book Value ($M)250.79
Book Value / Share4.09
Price / Book2.47
NCAV ($M)998.10
NCAV / Share16.28
Price / NCAV2.23
Income Statement (mra) ($M)
Revenue455.90
EBITDA24.51
Net Income-88.72
Balance Sheet (mrq) ($M)
Cash & Equivalents107.58
Cash / Share1.76
Assets1,059.51
Liabilities860.86
Quick Ratio1.29
Current Ratio1.35
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-0.35
Return on Assets (ROA)-0.07
Return on Equity (ROE)-0.35
Identifiers and Descriptors
CUSIP249908104
Central Index Key (CIK)1005201
Industry Groups
SIC 2834 - Pharmaceutical Preparations
Other Related CUSIPS
249908904
249908954
Share Statistics
Common Shares Outstanding (M)63.01
Scoring Models
Piotroski F Score5.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Inventory Work In Progress Per Share0.00
Liabilities And Stock Equity Per Share17.28
Long Term Debt Per Share0.00
Additional Paid In Capital Per Share1.24
Assets Other Non Current Per Share0.02
Treasury Stock Per Share0.00
Equity Per Share3.24
Accounts Payable Per Share0.00
Debt Per Share0.00
Cash And Equivalents Per Share1.76
Cash Per Share1.76
Liabilities Per Share14.04
Liabilities Other Non Current Per Share0.28
Property Plant And Equipment Per Share0.23
Intangibles Per Share13.46
Goodwill Per Share0.00
Inventory Raw Materials Per Share0.03
Assets Current Per Share3.58
Deferred Income Tax Liabilities Per Share0.00
Current Portion Of Long Term Debt Per Share0.00
Property Plant And Equipment Gross Per Share0.00
Assets Per Share17.28
Liabilities Current Per Share4.29
Retained Earnings Per Share-3.04
Property Plant And Equipment Net Per Share0.23
Assets Other Current Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Accumulated Depreciation And Depletion Per Share0.00
Inventory Per Share0.17
Minority Interest Per Share0.00
Inventory Finished Goods Per Share0.14
Accounts Receivable Per Share1.26

Related News Stories

BRIEF-Depomed Announces Closing Of Nucynta Commercialization Agreement With Collegium Pharmaceutical

2018-01-10 reuters
* DEPOMED INC - IN CONNECTION WITH CLOSING, CO RECEIVED AN UPFRONT $10 MILLION CASH PAYMENT FROM COLLEGIUM Source text for Eikon: Further company coverage: (8-0)

Depomed (DEPO) Depomed Announces NUCYNTA Commercialization Agreement with Collegium Pharmaceutical Conference (Transcript)

2017-12-06 seekingalpha
Good morning. And welcome to the Depomed Conference Call. Please note, this morning’s event is being recorded. (10-0)

Collegium Pharmaceutical: Updates To Thesis

2017-12-06 seekingalpha
Shares of Collegium Pharmaceutical (COLL) have risen by almost 75% since my article in late September called the firm "a key beneficiary of the opioid crisis". (10-1)

BRIEF-Depomed Announces Nucynta® Commercialization Agreement With Collegium Pharmaceutical

2017-12-04 reuters
* DEPOMED - PLANS TO RELOCATE ITS CORPORATE HEADQUARTERS FROM NEWARK, SOMETIME IN MID-2018 & IS CURRENTLY EVALUATING POTENTIAL MIDWEST & EAST COAST LOCATIONS (8-1)

CUSIP: 249908104